Most recently reported pay: $6.1M. No year-by-year proxy breakdown is on file — common for foreign private issuers and recently listed companies, which do not file a US proxy statement.
Names, titles and pay as reported by the company and its SEC filings, via Financial Modeling Prep. Reference only — nothing here is investment advice, and no affiliation with or endorsement by the people listed is implied.
Here's How ABT Broadens Diagnostics Growth Base With Oncology Expansion
Aug 7, 2026https://www.zacks.com/stock/news/2971097/here-s-how-abt-broadens-diagnostics-growth-base-with-oncology-expansion?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2971097sentiment +0.40
Abbott Laboratories Lost 16% This Year: One Analyst Sees 35% Gains for the Healthcare Giant
Aug 3, 2026https://247wallst.com/investing/2026/08/03/abbott-laboratories-lost-16-this-year-one-analyst-sees-35-gains-for-the-healthcare-giant/sentiment -0.10
One of the market's ‘most durable growth' sectors has been passed over for AI, says JPMorgan
Jul 30, 2026https://www.marketwatch.com/story/one-of-the-markets-most-durable-growth-sectors-has-been-passed-over-for-ai-says-jpmorgan-b726011csentiment +0.80
Aristotle Global Equity Advisory Q2 2026 Portfolio Review
Jul 30, 2026https://seekingalpha.com/article/4927420-aristotle-global-equity-advisory-q2-2026-portfolio-reviewsentiment -0.20
Danaher Gears Up to Post Q2 Earnings: Is a Beat in the Offing?
Jul 16, 2026https://www.zacks.com/stock/news/2955011/danaher-gears-up-to-post-q2-earnings-is-a-beat-in-the-offing?cid=CS-STOCKNEWSAPI-FT-analyst_blog|earnings_preview-2955011sentiment +0.40
Implied Volatility Surging for Danaher Stock Options
Jul 14, 2026https://www.zacks.com/stock/news/2953494/implied-volatility-surging-for-danaher-stock-options?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|options-2953494sentiment +0.40
